Keyphrases
Acetylsalicylic Acid
9%
Aggressive Lymphoma
6%
Allele Burden
9%
Antiplatelet Therapy
13%
ASXL1
13%
Atypical Chronic Myeloid Leukemia
6%
CBL Gene
6%
Chronic Neutrophilic Leukemia
6%
Clinical Outcomes
14%
Clinical Significance
7%
Clonal Dominance
6%
Clonality Assessment
6%
Diagnostic Accuracy
13%
Diagnostic Correlation
6%
Essential Thrombocythemia
100%
Evolutionary Patterns
7%
First-line Chemotherapy
6%
Frail Elderly
6%
Gene Expression Profiling
6%
Genotype
12%
Hematocrit
10%
High Risk
7%
Histological Criteria
6%
Hydroxycarbamide
14%
Hydroxyurea
20%
Intermediate Dose
6%
Isocitrate Dehydrogenase 1 (IDH1)
8%
JAK2V617F
55%
JAK2V617F mutation
32%
Janus Kinase 2 (JAK2)
23%
Low Risk
11%
Masked Polycythemia Vera
6%
Mass Measurement
6%
Molecular Response
13%
Mutation Pattern
6%
Myelofibrosis
10%
Myeloproliferative Neoplasms
42%
Natural Evolution
6%
Pegylated Liposomal Doxorubicin
6%
Phlebotomy
7%
Polycythemia Vera
83%
Red Cell Mass
7%
Risk Factors for Survival
6%
Serum Erythropoietin Level
6%
SETBP1
6%
Tet Methylcytosine Dioxygenase 2
10%
Thrombosis
23%
Thrombosis Risk
24%
Transformation Events
6%
Working Diagnosis
7%
Biochemistry, Genetics and Molecular Biology
Allele
30%
ASXL1
12%
CBL (Gene)
6%
CD34
10%
Clonal Variation
6%
Clonality
6%
DNMT3A
6%
Doxorubicin
6%
Dynamics
8%
Erythropoietin
6%
Essential Thrombocythaemia
53%
Gene Expression Profiling
6%
Genetic Predisposition
6%
Genotyping
5%
Granulocyte
8%
Haplotype
14%
Hematocrit
10%
Hematopoiesis
5%
Hematopoietic Stem Cell
6%
Hydroxycarbamide
20%
IDH1
6%
IDH2
6%
Janus Kinase
37%
Multivariate Analysis
8%
Phlebotomy
6%
Stem Cell
6%
Support Vector Machine
6%
Tissue Microarray
6%
Vision
6%
Medicine and Dentistry
Acetylsalicylic Acid
14%
Antiplatelet
13%
Atypical Chronic Myeloid Leukemia
6%
Bleeding
6%
Chronic Neutrophilic Leukemia
6%
Comorbidity
6%
Diagnostic Accuracy
6%
Diseases
5%
Essential Thrombocythaemia
44%
Gene Mutation
6%
Hazard Ratio
8%
Hydroxyurea
5%
Janus Kinase
10%
Leukemia
6%
Low Drug Dose
9%
Myelofibrosis
6%
Myeloid metaplasia
7%
Myeloproliferative Neoplasm
17%
Polycythemia vera
26%
Reproducibility
6%
Thrombosis
25%
